Genome Designs, Inc. was founded in January 2012 with a mission to help life scientists generate value from their sequencing projects, from functional annotation and metabolic modelling to drug development and advancement of bioproduction. This privately owned contract research service company is headed by an experienced team with a good track record in bioinformatics tool development, unique experience in metabolic engineering, a network of scientific collaborators and prior experience in start-up company operations. Using proprietary software tools (GD Annotation Suite) and MPW database, the largest collection of metabolic pathways curated since the 1980s, Genome Designs provides genome annotation, pathway analysis and metabolic engineering services, and licenses metabolic designs to pharmaceutical and bioproduction companies.